+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Novel Therapeutic Approaches for Treatment of Cancer

  • ID: 4607076
  • Report
  • July 2018
  • Region: Global
  • 15 pages
  • Frost & Sullivan
1 of 2

This Genetic Technology TOE depicts new life sciences trends across cancer treatment. Innovations related to the development of novel therapeutic approaches for the treatment of cancer, including senescent cells, CAR-T cell therapy, epitranscriptomics, and exosome production disruption, are profiled. The corresponding clinical trials scenario is also depicted.

The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Note: Product cover images may vary from those shown
2 of 2

Recent Advances in Development of Novel Therapeutic Approaches for Cancer

  • Targeting Senescent Cells to Battle Cancer and Reverse Ageing
  • Improvised CAR-T therapy for Solid Tumors
  • Leveraging Epitranscriptomics to Develop Cancer Treatments
  • Suppressing Cancer Metastasis by Disrupting Exosome Production

Clinical Trial Analysis and Key Contacts

  • Clinical Trial Analysis of Gene Therapy Treatments for Non-small Cell Lung Cancer (NSCLC)
  • Key Contacts
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll